BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Zimmer (ZMH) Told to Pay Stryker Corporation  (SYK) $70 Million in Patent Case


2/6/2013 8:29:51 AM

Zimmer Holdings Inc. was told to pay $70 million to Stryker Corp. for infringing patents related to a device that removes damaged tissue and cleans bones during joint-replacement surgery. Zimmer infringed three Stryker patents, a federal jury in Grand Rapids, Michigan, said today. The jury also found the infringement was willful, meaning U.S. District Judge Robert Jonker can increase the award. The dispute is over devices that use pulsing liquid, such as water or saline solution, to loosen debris from a surgical site and remove it by suction. The process clears the area for the doctors to see better during orthopedic surgery. “Stryker has some pioneering inventions,” said Greg Vogler, a lawyer at McAndrews Held & Malloy in Chicago, who represented Stryker in the trial. “Zimmer just took them recklessly and judgment day came.” Stryker’s claim targeted Zimmer’s Pulsavac products, which compete with Stryker’s Surgilav and InterPulse machines. The Pulsavac wound debridement system is part of Warsaw, Indiana-based Zimmer’s surgical unit, which generated $386 million in sales last year, or about 9 percent of the company’s revenue, Zimmer said Jan. 31. Pursuing Appeal: “Zimmer is disappointed with the verdict and plans to pursue all available post-trial relief including an appeal in due course,” said Garry Clark, a spokesman for Zimmer.

Read at Bloomberg
Read at Michigan Live
Read at News Release

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->